Oxidative stress and antioxidant status in β-thalassemia major: Iron overload and depletion of lipid-soluble antioxidants

Blood

Volumn 88, Issue 9, 1996, Pages 3608-3614

  Livrea, M A ^a   Tesoriere, L ^b   Pintaudi, A M ^b   Calabrese, A ^b   Maggio, A ^b   Freisleben, H J ^b   D'Arpa, D ^b   D'Anna, R ^b   Bongiorno, A ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINOTRANSFERASE; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; FERRITIN; GLUTATHIONE; IRON; LIPID HYDROPEROXIDE; LIPID PEROXIDE; LYCOPENE; MALONALDEHYDE; RETINOL; SERUM ALBUMIN; THIOBARBITURIC ACID; TROLOX C;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRON CHELATION; IRON OVERLOAD; LIVER INJURY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0029959755     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.9.3608.bloodjournal8893608     Document Type: Article

References (55)

1. Mulligan M, Althaus B, Linder MC: Non-ferritin, non-heme iron pools in rat tissues. Int J Biochem 18:791, 1986
2. Deighton N, Hider RC: Intracellular low molecular weight iron. Biochem Soc Trans 17:490, 1989
3. Britton RS, Ferrali M, Magiera CJ, Recknagel RO, Bacon BR: Increased prooxidant action of hepatic cytosol low-molecular-weight iron in experimental iron overload. Hepatology 11:1038, 1990
4. Hershko C, Graham G, Bates GW, Rachmilewitz EA: Non specific serum iron in thalassemia: An abnormal serum iron fraction of potential toxicity. Br J Haematol 40:255, 1978
5. Graham G, Bates GW, Rachmilewitz EA, Hershko C: Non specific serum iron in thalassemia: Quantitation and chemical reactivity. Am J Hematol 6:207, 1979
6. Wang WC, Ahmed N, Hanna M: Non transferrin-bound iron in long term transfusion in children with congenital anemias, J Pediatr 108:552, 1986
7. Gutteridge JMC, Rowley DA, Griffiths E, Halliwell B: Low molecular weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin Sci 68:463, 1985
8. Batey RG, Lai C-FP, Shamir S, Sherlok S: A non-transferrin-bound serum iron in idiopathic haemochromatosis. Dig Dis Sci 25:340, 1980
9. Grootveld M, Bell JD, Halliwell B, Aruoma OI, Bomford A, Sadler PJ: Non-transferrin-bound iron in plasma or serum from patients with idiopathic hemochromatosis. J Biol Chem 264:4417, 1989
10. Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: An overview, in Packer L, Glazer AN (eds): Methods in Enzymology, vol 186. San Diego, CA, Academic, 1990, p 1
11. Doroshow JH, Locker GY, Myers CE: Enzymatic defenses of the mouse heart against reactive oxygen metabolites. Alterations produced by doxorubicin. J Clin Invest 65:128, 1980
12. Aldouri MA, Hoffbrand AV, Flynn DM, Ward SE, Agnew JE, Hilson AJW: High incidence of cardiomyopathy in beta-thalassemia patients receiving regular transfusions and iron chelation: Reversal by intensified chelation. Acta Haematol 84:113, 1990
13. Zannos-Mariolea L, Tzortzatou F, Dendaki-Svolaki K, Katerellos C, Kavallari M, Matsaniotis N: Serum vitamin E levels with beta-thalassemia major:preliminary report. Br J Haematol 26:193, 1974
14. Zannos-Mariolea L, Papagregoriou-Theodoridou M, Costantzas N, Matsaniotis N: Relationship between tocopherols and serum lipid levels in children with β-thalassemia major. Am J Clin Nutr 31:259, 1978
15. Rachmilewitz EA, Shifter A, Kahane I: Vitamin E deficiency in β-thalassemia major: Changes in hematological and biochemical parameters after a therapeutic trial with α-tocopherol. Am J Clin Nutr 32:1850, 1979
16. Giardini O, Cantani A, Donfrancesco A, Martino F, Mannarino O, D'Eufemia P, Miano C, Ruberto U, Lubrano R: Biochemical and clinical effects of vitamin E administration in homozigous beta-thalassemia. Acta Vitaminol Enzymol 7:55, 1985
17. Magrin S, Craxi' A, Fabiano C, Simonetti RG, Fiorentino G, Marino L, Diquattro O, Di Marco V, Loiacono O, Volpes R, Almasio P, Urdea MS, Neuwald P, Sanchez-Pescador R, Detmer J, Wilber JC, Pagliaro L: Hepatitis C viremia in chronic liver disease: Relationship to interferon-alpha or corticosteroid treatment. Hepatology 19:273, 1994
18. Craxi' A, Valenza M, Fabiano C, Magrin S, Fiorentino G, Diquattro O, Pagliaro L: Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors. J Hepatol 21:730, 1994
19. Singh S, Hider RC, Porter JB: A direct method for quantification of non-transferrin-bound iron. Anal Biochem 186:320, 1990
20. Zhang D, Okada S, Kawabata T, Yasuda T: An improved simple colorimetric method for quantitation of non-transferrin-bound iron in serum. Biochem Mol Biol Int 35:635, 1995
21. Pryor WA, Castle L: Chemical methods for detection of lipid hydroperoxides, in Packer L (ed): Methods in Enzymology, vol 105. Orlando, FL, Academic, 1984, p 293
22. Buege JA, Aust SD: Microsomal lipid peroxidation, in Fleischer S, Packer L (eds): Methods in Enzymology, vol 52. New York, NY, Academic, 1978, p 302
23. Levine RL, Williams JA, Stadtman ER, Shacter E: Carbonyl assays for determination of oxidatively modified proteins, in Packer L (ed): Methods in Enzymology, vol 233. San Diego, CA, Academic, 1994, p 346
24. Garibaldi S, Aragno I, Odetti P, Marinari UM: Relationships between protein carbonyls, retinol and tocopherols level in human plasma. Biochem Mol Biol Int 34:729, 1994
25. Rice-Evans C, Miller NJ: Total antioxidant status in plasma and body fluids, in Packer L (ed): Methods in Enzymology, vol 234. San Diego, CA, Academic, 1994, p 279
26. Kraft NE: Carotenoid reversed-phase high performance liquid chromatography methods: Reference compendium, in Packer L (ed): Methods in Enzymology, vol 213. San Diego, CA, Academic, 1992, p 185
27. Lazzarino G, Di Pierro D, Tavazzi B, Cerroni L, Giardina B: Simultaneous separation of malondialdehyde, ascorbic acid, and adenine nucleotide derivates from biological samples by ion-pairing high-performance liquid chromatography. Anal Biochem 197:191, 1991
28. Hu M-L: Measurement of protein thiol groups and glutathione in plasma, in Packer L (ed): Methods in Enzymology, vol 233. San Diego, CA, Academic, 1994, p 380
29. Maioli M, Cuccuru GB, Pranzetti P, Pacifico A, Cherchi GM: Plasma lipids and lipoprotein pattern in beta-thalassemia major. Acta Haematol 71:106, 1984
30. Giardini O, Murgia F, Martino F, Mannarino O, Corrado G, Maggioni G: Serum lipid pattern in β-thalassemia. Acta Haematol 60:100, 1978
31. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A: A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 84:407, 1993
32. Wagstaff M, Peters SW, Jones BM, Jacobs A: "Free" iron and iron toxicity in iron overload. Br J Haematol 61:566, 1985
33. Young IS, Trouton TG, Torney JJ, McMaster D, Callender ME, Trimble ER: Antioxidant status and lipid peroxidation in hereditary haemochromatosis. Free Radic Biol Med 16:393, 1994
34. Rachmilewitz EA, Lubin BH, Shohet SB: Lipid membrane peroxidation in β-thalassemia major. Blood 47:495, 1976
35. Han KE, Okada S: Serum bleomycin-detectable iron in patients with thalassemia major with normal range of serum iron. Acta Med Okayama 49:117, 1995
36. Al-Refaie FN, Wickens DG, Wonke B, Kontoghiorghes GJ, Hoffbrand AV: Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1. Br J Haematol 82:431, 1992
37. Miller NJ, Paganga G, Wiseman S, Nielen WV, Tijburg L, Chowienczyk P, Rice-Evans CA: Total antioxidant activity of low density lipoproteins and the relationship with α-tocopherol status. FEBS Lett 365:164, 1995
38. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young IS: Effects of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 41:1135, 1995
39. Wapnick AA, Lynch SR, Krawitz P, Seftel HC, Charlton RW, Bothwell TH: Effects of iron overload on ascorbic acid metabolism. BMJ 3:704, 1968
40. Stocker R, Frei B: Endogenous antioxidant defences in human blood plasma, in Sies H (ed): Oxidative Stress: Oxidants and Antioxidants. New York, NY, Academic, 1991, p 213
41. Jacob RA: The integrated antioxidant system. Nutr Res 15:755, 1995
42. Rice-Evans C, Baysal E: Iron-mediated oxidative stress in erythrocytes. Biochem J 244:191, 1987
43. Horwitt MK, Harvey CC, Dahm CH, Searcy MT: Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann NY Acad Sci 203:223, 1972
44. Jordan P, Brubacher D, Moser U, Stahelin HB, Gey KF: Vitamin E and vitamin A concentrations in plasma adjusted for cholesterol and triglycerides by multiple regression. Clin Chem 41:924, 1995
45. Omara FO, Blakley BR: Vitamin E is protective against iron toxicity and iron-induced hepatic vitamin E depletion in mice. J Nutr 123:1649, 1993
46. Ward RJ, Florence AL, Baldwin DPE, Peters TJ, Crichton RR: Biochemical and biophysical investigations of the ferrocene iron-loaded rat. An animal model of primary haemochromatosis. Eur J Biochem 202:405, 1991
47. Resow B, Albert C, Zimmermann I, Nielsen P: Ethane exhalation and vitamin E/ubiquinol status as markers of lipid peroxidation in ferrocene iron-loaded rats. Hepatology 21:1099, 1995
48. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, Bacon BR: Measurements of iron status in patients with chronic hepatitis. Gastroenterology 102:2108, 1992
49. Leo MA, Rosman AS, Lieber CS: Differential depletion of carotenoids and tocopherol in liver disease. Hepatology 17:977, 1993
50. von Herbay A, de Groot H, Hegi U, Stremmel W, Strohmeyer G, Sies H: Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatol 20:41, 1994
51. Tesoriere L, Bongiorno A, Re R, Livrea MA: Reciprocal protective effects of all-trans retinol and α-tocopherol during lipid peroxidation in retinal membranes. Biochem Mol Biol Int 37:1, 1995
52. Tesoriere L, Bongiorno A, Pintaudi AM, D'Anna R, D'Arpa D, Livrea MA: Synergistic interactions between vitamin A and vitamin E against lipid peroxidation in phosphatidylcholine liposomes. Arch Bioch Biophys 326:57, 1996
53. Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan T: Most free-radical injury is iron-related: It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 12:289, 1994
54. Hatori M, Sparkman J, Teixeira CC, Grynpas M, Nervina J, Olivieri N, Shapiro IM: Effects of deferoximine on chondrocyte alkaline phosphatase activity: Proxidant role of deferoximine in thalassemia. Calcif Tissue Int 57:229, 1995
55. Rachmilewitz EA, Shinar E, Shalev O, Galili U, Schrier SI: Erythrocyte membrane alterations in β-thalassaemia. Clin Haematol 14:163, 1985